Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7.96 CHF | -1.49% | +11.33% | +128.08% |
Apr. 24 | Kuros Biosciences Posts Higher Q1 Product Sales | MT |
Apr. 17 | Kuros Biosciences AG Approves Board of Director and Committee Changes | CI |
Business Summary
Number of employees: 80
Sales per Business
CHF in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Medical Devices
100.0
%
| 13 | 73.8 % | 34 | 100.0 % | +153.03% |
Sales per region
CHF in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
97.8
%
| 17 | 96.6 % | 33 | 97.8 % | +88.93% |
European Union
1.7
%
| 0 | 2.4 % | 1 | 1.7 % | +35.20% |
Other
0.4
%
| 0 | 1.0 % | 0 | 0.4 % | -17.82% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Joost de Bruijn
FOU | Founder | 58 | 17-12-03 |
Christopher Fair
CEO | Chief Executive Officer | 54 | 21-04-18 |
Daniel Geiger
DFI | Director of Finance/CFO | - | 23-02-16 |
Chief Tech/Sci/R&D Officer | - | 16-12-31 | |
Sjoerd Musters
COO | Chief Operating Officer | - | 22-09-30 |
Luuk van Dijk
CTO | Chief Tech/Sci/R&D Officer | - | 14-12-31 |
Katherine Sage
CTO | Chief Tech/Sci/R&D Officer | - | 20-12-31 |
John Griffin
PRN | Corporate Officer/Principal | - | 23-10-11 |
Marcel Borger
LAW | General Counsel | - | 19-12-31 |
Philippe Saudan
PRN | Corporate Officer/Principal | 57 | 16-08-09 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Scott P. Bruder
BRD | Director/Board Member | 62 | 18-06-13 |
Christopher Fair
CEO | Chief Executive Officer | 54 | 21-04-18 |
Joost de Bruijn
FOU | Founder | 58 | 17-12-03 |
Chairman | 67 | 17-05-22 | |
Oliver Walker
BRD | Director/Board Member | 55 | 18-06-13 |
Leanna Caron
BRD | Director/Board Member | 56 | 16-06-15 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 36,922,274 | 23,914,004 ( 64.77 %) | 17,244 ( 0.0467 %) | 64.77 % |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
KUROS BIOSCIENCES AG 3.15% | 1,160,106 | 3.15% | 8,196,578 $ |
Company contact information
Sector
Sales per Business
Sales per region
1st Jan change | Capi. | |
---|---|---|
+128.08% | 330M | |
+9.42% | 114B | |
+11.84% | 104B | |
-14.15% | 22.41B | |
-1.05% | 22.28B | |
-5.29% | 19.07B | |
-38.29% | 18B | |
-4.16% | 17.89B | |
+7.99% | 14.28B | |
+36.24% | 12.55B |
- Stock Market
- Equities
- KURN Stock
- Company Kuros Biosciences AG